Facebook
Twitter
LinkedIn
Forward| Title | Program description | Type | Credit | Event date |
|---|---|---|---|---|
| General Principles in Tuberculosis (TB) Management - 12:00 p.m. Central Time |
September 20, 2024 - Webinar - Broadcast in Central Time This session focuses on the essential aspects of TB management, highlighting the importance of partnering with Public Health. Participants will review key principles in pulmonary and extrapulmonary TB management, primary treatment regimens for drug-susceptible and drug-resistant TB, and the conditions necessary to start combination drug therapy. This session equips healthcare providers with practical knowledge to enhance TB patient outcomes. |
Live |
|
09/20/2024 |
| Latent Tuberculosis Infection: Diagnosis, Treatment, and Management for Primary Care Providers - 7:00 a.m. Central Time |
September 25, 2024 - Webinar - Broadcast in Central Time Latent Tuberculosis Infection (LTBI) is a significant public health concern due to its potential to progress to active TB if untreated. This session will provide healthcare providers with essential knowledge on LTBI, including distinguishing it from active TB, accurately diagnosing it using TST and IGRAs and treating it with current regimens. The session will also explore strategies for effectively managing LTBI patients, emphasizing patient education, adherence, and collaboration with public health resources, ensuring that any healthcare provider can confidently manage LTBI cases. |
Live |
|
09/25/2024 |
| Latent Tuberculosis Infection: Diagnosis, Treatment, and Management for Primary Care Providers - 12:00 p.m. Central Time |
September 25, 2024 - Webinar - Broadcast in Central Time Latent Tuberculosis Infection (LTBI) is a significant public health concern due to its potential to progress to active TB if untreated. This session will provide healthcare providers with essential knowledge on LTBI, including distinguishing it from active TB, accurately diagnosing it using TST and IGRAs and treating it with current regimens. The session will also explore strategies for effectively managing LTBI patients, emphasizing patient education, adherence, and collaboration with public health resources, ensuring that any healthcare provider can confidently manage LTBI cases. |
Live |
|
09/25/2024 |
| Unique Considerations in Pediatric Tuberculosis - 7:00 a.m. Central Time |
September 13, 2024 - Webinar - Broadcast in Central Time This session will delve into the distinct characteristics of tuberculosis (TB) in children compared to adults. Participants will examine variations in TB occurrence, risk factors, and how the disease manifests in young patients. The session will also address the differences in diagnosing TB in children, including interpreting chest X-rays and utilizing tests like IGRAs. Finally, the discussion will focus on the unique factors to consider when treating TB in children, covering both latent infection and active disease. |
Live |
|
09/13/2024 |
| Unique Considerations in Pediatric Tuberculosis - 12:00 p.m. Central Time |
September 13, 2024 - Webinar - Broadcast in Central Time This session will delve into the distinct characteristics of tuberculosis (TB) in children compared to adults. Participants will examine variations in TB occurrence, risk factors, and how the disease manifests in young patients. The session will also address the differences in diagnosing TB in children, including interpreting chest X-rays and utilizing tests like IGRAs. Finally, the discussion will focus on the unique factors to consider when treating TB in children, covering both latent infection and active disease. |
Live |
|
09/13/2024 |
| Emerging Infections in Clinical Practice and Public Health 2024 |
November 22, 2024 - InterContinental Minneapolis-St. Paul Airport - St. Paul, Minnesota This course offers Live (in-person) attendance. Preventing, controlling and treating emerging infections continue to be an essential focus for clinicians, infection control and public health practitioners, and laboratorians. This continuing education conference in its 30th year, provides a forum for authoritative presentations and discussions on the epidemiology, prevention and control of emerging infectious diseases. Topics include the new RSV vaccines and treatments, antibiotic resistance in Candida auris, and the emerging field of phage therapy for antibiotic resistant infections. |
Live |
|
11/22/2024 |